Plymouth Meeting, Pennsylvania

Harmony Biosciences Announces Date of Third Quarter 2021 Financial Results

Retrieved on: 
Tuesday, October 26, 2021
Paragon, Plymouth Meeting, Pennsylvania, Patient, LLC, Company, Harmony, Lists of diseases, Pharmaceutical industry, Internet service provider

PLYMOUTH MEETING, Pa., Oct. 26, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that it will issue a press release on the Company's third quarter 2021 financial results on Tuesday, November 9, 2021. Following the release, Harmony will conduct a conference call and live webcast on the same day, at 8:30 a.m. ET.

Key Points: 
  • PLYMOUTH MEETING, Pa., Oct. 26, 2021 /PRNewswire/ --Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that it will issue a press release on the Company's third quarter 2021 financial results on Tuesday, November 9, 2021.Following the release, Harmony will conduct a conference call and live webcast on the same day, at 8:30 a.m.
  • To participate in the call, please dial(833) 614-1471 (domestic) or +1 (914) 987-7209 (international), and reference passcode 4387084.
  • Harmony Biosciences is a commercial stage pharmaceutical company headquartered in Plymouth Meeting, PA.
  • The Company was established by Paragon Biosciences, LLC, and is focused on providing novel treatment options for people living with rare neurological diseases who have unmet medical needs.

Core & Main Signs Definitive Agreement to Acquire Catalone Pipe & Supply

Retrieved on: 
Tuesday, October 19, 2021
Utilities, Other Construction & Property, Manufacturing, Energy, Construction & Property, Building Systems, Other Manufacturing, Drainage, Private Securities Litigation Reform Act, Person, U.S. Securities and Exchange Commission, NYSE, Catalone, Security (finance), Water, Terminology, Core & Main, State College, Pennsylvania, CNM, Solution, Plymouth Meeting, Pennsylvania, Plumbing, Risk management

A full-service provider like Catalone Pipe & Supply aligns with the dependable expertise we offer throughout the waterworks industry.

Key Points: 
  • A full-service provider like Catalone Pipe & Supply aligns with the dependable expertise we offer throughout the waterworks industry.
  • Were excited to expand our waterworks footprint in the Northeast, said Jack Schaller, president of Core & Main Waterworks.
  • The group at Catalone Pipe & Supply works hard to exceed their customers expectations and deliver quality products.
  • Craig Catalone, president of Catalone Pipe & Supply, said, I believe our team at Catalone Pipe & Supply is second to none.

ECRI CEO Marcus Schabacker Named 2021 Healthcare Leader

Retrieved on: 
Wednesday, October 13, 2021
Leadership, View, Fear, History, Office of Inspector General, U.S. Department of Health and Human Services, Evidence-based medicine, Quality, Plymouth Meeting, Pennsylvania, Agency for Healthcare Research and Quality, Doctor of Philosophy, Patient safety organization, Asia, National Resource Center for Health Information Technology, School, U.S. Agency for Global Media, Multimedia, United Kingdom, American City Business Journals, Human services, PPE, PSO, U.S. Department of Defense Strategy for Operating in Cyberspace, Uncertainty, ECRI, Personal protective equipment, Richard Barker (life sciences and healthcare leader), Mask, CEO, Institute, United Arab Emirates, Safety, MD, Patient safety, COVID-19, Pharmaceutical industry, Management, Online shopping

PLYMOUTH MEETING, Pa., Oct. 13, 2021 /PRNewswire/ -- Marcus Schabacker, MD, PhD, president and chief executive officer of ECRI, an independent nonprofit organization that improves the safety, quality, and cost-effectiveness of healthcare, has been honored by the Philadelphia Business Journal with a Leaders in Healthcare 2021 Award.

Key Points: 
  • PLYMOUTH MEETING, Pa., Oct. 13, 2021 /PRNewswire/ -- Marcus Schabacker, MD, PhD, president and chief executive officer of ECRI, an independent nonprofit organization that improves the safety, quality, and cost-effectiveness of healthcare, has been honored by the Philadelphia Business Journal with a Leaders in Healthcare 2021 Award.
  • Schabacker took important steps in early 2020 to prepare the healthcare community for what would become a global pandemic.
  • For more information about Marcus Schabacker and ECRI's role in guiding the healthcare community and the public with evidence-based guidance, download the ECRI COVID-19 Journey .
  • Philadelphia Business Journal honors @SchabackerECRI, CEO of @ECRI_Org with Leaders in Healthcare 2021 Award
    ECRI is an independent, nonprofit organization improving the safety, quality, and cost-effectiveness of care across all healthcare settings.

Harmony Biosciences Announces Winners of Patients at the Heart and Progress at the Heart on Third Annual World Narcolepsy Day

Retrieved on: 
Wednesday, September 22, 2021
Paragon, Sickle cell disease, Population, Degenerative disease, Focus group, List of Hindawi academic journals, Program, Mental health, Focus, Sleep disorder, Obesity, Community health center, Initiative, Progress, Sleep, Lists of diseases, Heart, Excessive daytime sleepiness, Awareness, SCD, PWSA, CHC, Intern Academy, Patient, Fitbit, SVP, Narcolepsy, DEI, Caregiver, Harmony, Prader–Willi syndrome, Poverty, Impact of the COVID-19 pandemic on African-American communities, Company, LLC, Public policy, HF, Plymouth Meeting, Pennsylvania, Organization, Diagnosis, Treatment, Weight loss, PWS, EDS, African Americans, Prevalence, Corporate Affairs, Parent, Pharmaceutical industry, Medical device, Medicine

Initiated in 2021, Progress at the Heart supports innovative programs that address disparities, injustice, and inequities in the rare disease and sleep disorder community.

Key Points: 
  • Initiated in 2021, Progress at the Heart supports innovative programs that address disparities, injustice, and inequities in the rare disease and sleep disorder community.
  • "We are so inspired by the diverse and inventive programs submitted for this year's Patients and Progress at the Heart programs," said Cate McCanless, SVP, Corporate Affairs and Public Policy.
  • The company chose to announce the winners on World Narcolepsy Day, a day dedicated to raising awareness for this sleep disorder globally.
  • The first Patients at the Heart program awarded $65,000 to four organizations, which was increased to $74,000 in 2020.

Harmony Biosciences To Participate In Three Investor Conferences In September

Retrieved on: 
Thursday, September 2, 2021
Paragon, Patient, Plymouth Meeting, Pennsylvania, LLC, CEO, Company, Lists of diseases, Harmony, Pharmaceutical industry

PLYMOUTH MEETING, Pa., Sept. 2, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated todeveloping and commercializing innovative therapies for patients with rare neurological diseases, today announced that Harmony's President and CEO, John C. Jacobs, will participate in fireside chats and host investor meetings at the following upcoming virtual conferences:

Key Points: 
  • PLYMOUTH MEETING, Pa., Sept. 2, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated todeveloping and commercializing innovative therapies for patients with rare neurological diseases, today announced that Harmony's President and CEO, John C. Jacobs, will participate in fireside chats and host investor meetings at the following upcoming virtual conferences:
    Harmony Biosciences is a commercial stage pharmaceutical company headquartered in Plymouth Meeting, PA.
  • The Company was established by Paragon Biosciences, LLC, and is focused on providing novel treatment options for people living with rare neurological diseases who have unmet medical needs.
  • For more information on Harmony, please visit the company's website: www.harmonybiosciences.com .

Ayr Wellness Announces the Launch of Origyn Extracts in Pennsylvania

Retrieved on: 
Thursday, September 2, 2021
Company, Plymouth Meeting, Pennsylvania, LLC, Mark (given name), Timeline of cannabis laws in the United States, Transport, CSE, Commonwealth, Acquisition, GLOBE, Research, Financial management, Forward-looking statement, OTC, Contract, News, Patient, Cannabis, CEO, Cornbread, COVID-19, Letter, Hospital, Drug, Risk management

NEW YORK, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Ayr Wellness Inc. (CSE: AYR.A, OTC: AYRWF) (Ayr or the Company), a leading vertically integrated cannabis multi-state operator, today announced the launch of its Origyn Extracts premium concentrates line in Pennsylvania.

Key Points: 
  • NEW YORK, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Ayr Wellness Inc. (CSE: AYR.A, OTC: AYRWF) (Ayr or the Company), a leading vertically integrated cannabis multi-state operator, today announced the launch of its Origyn Extracts premium concentrates line in Pennsylvania.
  • Pennsylvania marks the fourth state where Origyn, part of Ayrs growing national brand portfolio, is being sold.
  • Sales of Origyn in Pennsylvania began yesterday, available exclusively in Ayrs three Pennsylvania dispensaries Plymouth Meeting, New Castle and Gibsonia.
  • Jonathan Sandelman, CEO of Ayr, said, Were pleased to provide Pennsylvanians with access to Origyn Extracts, a concentrates brand that celebrates the high quality of the flower that we grow.

Convergent Expands into Philadelphia and Partners with Helm

Retrieved on: 
Wednesday, July 14, 2021
Business, Articles, Economy, Cloud infrastructure, Cloud computing, Managed services, UST

Convergent is a technology partner specializing in advanced solutions for customers located throughout the United States.With over 45 years of serving clients, our team has grown into a solution provider implementing and managing data center infrastructure, unified communications, and cloud solutions.We have grown our business by aligning technology to the business needs of our clients and delivering a single source of accountability across all aspects of their infrastructure.

Key Points: 
  • Convergent is a technology partner specializing in advanced solutions for customers located throughout the United States.With over 45 years of serving clients, our team has grown into a solution provider implementing and managing data center infrastructure, unified communications, and cloud solutions.We have grown our business by aligning technology to the business needs of our clients and delivering a single source of accountability across all aspects of their infrastructure.
  • Today, Convergent is proud to be a respected technology company by our clients, the business partners, and service provider partners we represent.
  • In a world dominated by rapid changes in technology, Convergent's philosophy is a commitment to excellence and simplicity for our customers.For more information about Convergent, please visit www.askconvergent.com .
  • Helm Partners is a technology advisory services firm helping reshape businesses for growth and achieve better outcomes throughout their digital transformation journey.Helm provides a roadmap for purposeful change.Located in Plymouth Meeting, Pennsylvania, Helm has been a trusted advocate for their global client base since 2001.Helm's core practices focus on cloud communications, contact center solutions, nextgen network strategies, cyber security, cloud and managed services, and expense management, supporting clients from assessment through implementation and the ongoing lifecycle.From insight comes action, take the Helm.

Ideal Image Continues to Strengthen Point of Care Network with Pennsylvania Opening

Retrieved on: 
Thursday, March 25, 2021
Regions of the United States, Geography of the United States, Geography of Pennsylvania, Germantown Pike, Germantown, Philadelphia, Willow Grove, iDEAL, Germantown, Maryland, Plymouth Meeting, Pennsylvania, King of Prussia, Pennsylvania, PENNSYLVANIA, Aesthetics

TAMPA, Fla., March 25, 2021 (GLOBE NEWSWIRE) -- Ideal Image ,the #1 Aesthetics Brand in North America, today opened its sixth Pennsylvania point of care location at 500 W Germantown Pike, Suite 1725 in Plymouth Meeting.

Key Points: 
  • TAMPA, Fla., March 25, 2021 (GLOBE NEWSWIRE) -- Ideal Image ,the #1 Aesthetics Brand in North America, today opened its sixth Pennsylvania point of care location at 500 W Germantown Pike, Suite 1725 in Plymouth Meeting.
  • Ideal Image also has locations in King of Prussia, Willow Grove, Philadelphia, Langhorne and Bethlehem, Pennsylvania.
  • From there guests are able to select the most convenient clinic in Ideal Images point of care network to receive their treatment plan.
  • Ideal Image is North Americas #1 aesthetics brand, making personal aesthetic and wellness services more affordable, accessible and effective than ever before.

Ayr Wellness Announces Opening of Second Dispensary in Pennsylvania

Retrieved on: 
Wednesday, February 24, 2021
Ayr, Firth of Clyde, Towns in the United Kingdom, Plymouth Meeting, Pennsylvania, Germantown Pike, Geography of Scotland, Scotland

Ayr Wellness Plymouth Meeting Grand Opening Scheduled for February 26, 2021

Key Points: 
  • Ayr Wellness Plymouth Meeting Grand Opening Scheduled for February 26, 2021
    TORONTO, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Ayr Wellness (CSE: AYR.A, OTCQX: AYRWF, Ayr or the Company), a leading vertically integrated cannabis multi-state operator, announced the opening of its second medical dispensary in the Commonwealth of Pennsylvania, located in the Philadelphia suburb of Plymouth Meeting.
  • The dispensary, the second to open under the Ayr Wellness banner in Pennsylvania, is located at 505 W. Germantown Pike, Plymouth Meeting, PA.
  • We are thrilled to be expanding in the Pennsylvania medical market with the opening of our second Ayr Wellness dispensary.
  • We look forward to bringing our highest-quality cannabis products to the Pennsylvania market soon, said Ayr Wellness CEO Jonathan Sandelman.